Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 100.00 | -- | 125.00 | 125.00 | 125.00 | 156.00 |
| Gross Profit | -100.00 | -- | -125.00 | -125.00 | -125.00 | -156.00 |
| Selling General And Administration | 996,453 | -- | 236,829 | 157,845 | 91,861 | 145,980 |
| General And Administrative Expense | 948,021 | -- | 169,808 | 102,251 | 46,174 | 85,014 |
| Other Operating Expenses | 357,854 | -- | 451,334 | 1.3M | 894,789 | 519,338 |
| Operating Expense | 1.4M | -- | 688,163 | 1.4M | 986,650 | 665,318 |
| Operating Income | -1.4M | -- | -688,288 | -1.4M | -986,775 | -665,474 |
| EBIT | -1.4M | -- | -677,486 | -1.4M | -986,775 | -665,474 |
| Interest Expense | -- | -- | 1,047 | -- | -- | -- |
| Interest Expense Non Operating | -- | -- | 1,047 | -- | -- | -- |
| Interest Income | 386.00 | -- | -- | 2,095 | 4,782 | 20,564 |
| Interest Income Non Operating | 386.00 | -- | -- | 2,095 | 4,782 | 20,564 |
| Net Interest Income | 386.00 | -- | -1,047 | 2,095 | 4,782 | 20,564 |
| Other Income Expense | 81,542 | -- | 10,802 | 51,035 | -39,443 | -385,733 |
| Special Income Charges | 39,326 | -- | -- | -- | 0.00 | -72,910 |
| Gain On Sale Of Security | 86,192 | -- | -28,238 | 51,035 | -39,443 | -165,211 |
| Earnings From Equity Interest | -43,976 | -- | 39,040 | 0.00 | 0.00 | -147,612 |
| Pretax Income | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Tax Effect Of Unusual Items | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Net Income From Continuing Operation Net Minority Interest | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Net Income Including Noncontrolling Interests | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Net Income Common Stockholders | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Net Income | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| EBITDA | -1.3M | -- | -666,454 | -1.4M | -975,743 | -649,683 |
| Normalized EBITDA | -1.5M | -- | -638,216 | -1.5M | -936,300 | -411,562 |
| Reconciled Depreciation | 10,468 | -- | 11,032 | 11,032 | 11,032 | 15,791 |
| Basic EPS | 0.00 | -- | 0.00 | 0.00 | 0.00 | -- |
| Diluted EPS | 0.00 | -- | 0.00 | 0.00 | 0.00 | -- |
| Basic Average Shares | 339.8M | -- | 329.1M | 292.4M | 286.8M | -- |
| Diluted Average Shares | 339.8M | -- | 329.1M | 292.4M | 286.8M | -- |
| Total Unusual Items | 125,518 | -- | -28,238 | 51,035 | -39,443 | -238,121 |
| Total Unusual Items Excluding Goodwill | 125,518 | -- | -28,238 | 51,035 | -39,443 | -238,121 |
| Tax Rate For Calcs | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -1.4M | -- | -650,295 | -1.4M | -981,993 | -792,522 |
| Diluted NI Availto Com Stockholders | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Gain On Sale Of Ppe | 39,326 | -- | -- | -- | 0.00 | 9,590 |
| Impairment Of Capital Assets | -- | -- | -- | -- | -- | 82,500 |
| Net Income Continuous Operations | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Net Non Operating Interest Income Expense | 386.00 | -- | -1,047 | 2,095 | 4,782 | 20,564 |
| Other Gand A | 45,926 | -- | 144,412 | 85,314 | 29,517 | 52,970 |
| Reconciled Cost Of Revenue | 100.00 | -- | 125.00 | 125.00 | 125.00 | 156.00 |
| Salaries And Wages | 902,095 | -- | 25,396 | 16,937 | 16,657 | 32,044 |
| Selling And Marketing Expense | 48,432 | -- | 67,021 | 55,594 | 45,687 | 60,966 |
| Total Expenses | 1.4M | -- | 688,288 | 1.4M | 986,775 | 665,474 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.8M | -- | 864,044 | 1.5M | 1.5M | 2.5M |
| Cash Cash Equivalents And Short Term Investments | 2.1M | -- | 1.3M | 1.9M | 1.9M | 3.0M |
| Other Short Term Investments | 228,188 | -- | 401,083 | 449,506 | 467,251 | 506,694 |
| Accounts Receivable | 3,450 | -- | 1,725 | 1,725 | 3,450 | 5,887 |
| Receivables | 43,537 | -- | 209,218 | 165,735 | 121,009 | 94,751 |
| Prepaid Assets | 39,258 | -- | 59,770 | 60,040 | 39,600 | 45,115 |
| Other Current Assets | -- | -- | -- | 1.00 | -- | -- |
| Current Assets | 2.1M | -- | 1.5M | 2.2M | 2.1M | 3.2M |
| Gross PPE | 1.2M | -- | 1.3M | 1.3M | 1.3M | 1.3M |
| Accumulated Depreciation | -160,728 | -- | -268,859 | -257,827 | -246,795 | -235,763 |
| Net PPE | 1.1M | -- | 1.0M | 1.0M | 1.0M | 1.0M |
| Investments And Advances | 1.9M | -- | 3.9M | 3.9M | 3.9M | 3.9M |
| Long Term Equity Investment | 1.9M | -- | 3.9M | 3.9M | 3.9M | 3.9M |
| Total Non Current Assets | 3.0M | -- | 4.9M | 4.9M | 4.9M | 4.9M |
| Total Assets | 5.1M | -- | 6.4M | 7.0M | 7.0M | 8.1M |
| Accounts Payable | -- | -- | 78,450 | -- | -- | -- |
| Payables | -- | -- | 88,581 | -- | -- | -- |
| Payables And Accrued Expenses | 161,747 | -- | 88,581 | 222,523 | 39,700 | 264,289 |
| Current Accrued Expenses | -- | -- | -- | -- | 39,700 | -- |
| Current Liabilities | 241,747 | -- | 88,581 | 222,523 | 39,700 | 264,289 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | -- | 0.00 | 0.00 | 155,110 | 0.00 |
| Total Liabilities Net Minority Interest | 241,747 | -- | 88,581 | 222,523 | 194,810 | 264,289 |
| Common Stock | 44.3M | -- | 44.3M | 44.1M | 42.7M | 42.7M |
| Capital Stock | 44.3M | -- | 44.3M | 44.1M | 42.7M | 42.7M |
| Additional Paid In Capital | 10.0M | -- | 9.7M | 9.7M | 9.7M | 9.7M |
| Retained Earnings | -49.5M | -- | -47.8M | -47.1M | -45.8M | -44.7M |
| Common Stock Equity | 4.9M | -- | 6.3M | 6.8M | 6.8M | 7.8M |
| Stockholders Equity | 4.9M | -- | 6.3M | 6.8M | 6.8M | 7.8M |
| Total Equity Gross Minority Interest | 4.9M | -- | 6.3M | 6.8M | 6.8M | 7.8M |
| Total Capitalization | 4.9M | -- | 6.3M | 6.8M | 6.8M | 7.8M |
| Net Tangible Assets | 4.9M | -- | 6.3M | 6.8M | 6.8M | 7.8M |
| Tangible Book Value | 4.9M | -- | 6.3M | 6.8M | 6.8M | 7.8M |
| Working Capital | 1.9M | -- | 1.4M | 2.0M | 2.1M | 2.9M |
| Invested Capital | 4.9M | -- | 6.3M | 6.8M | 6.8M | 7.8M |
| Share Issued | 356.7M | -- | 331.5M | 325.2M | 286.8M | 286.8M |
| Ordinary Shares Number | 356.7M | -- | 331.5M | 325.2M | 286.8M | 286.8M |
| Accrued Interest Receivable | 900.00 | -- | 190.00 | 2,947 | 2,116 | 17,082 |
| Current Deferred Liabilities | 80,000 | -- | -- | -- | -- | -- |
| Dueto Related Parties Current | -- | -- | 10,131 | -- | -- | -- |
| Investmentsin Associatesat Cost | 1.9M | -- | 3.9M | 3.9M | 3.9M | 3.9M |
| Investmentsin Joint Venturesat Cost | -- | -- | -- | 3.9M | 3.9M | 3.9M |
| Machinery Furniture Equipment | 217,876 | -- | 312,512 | 312,512 | 312,512 | 312,512 |
| Other Equity Interest | 148,516 | -- | 142,930 | 133,219 | 119,212 | 119,212 |
| Other Properties | 1.0M | -- | 968,233 | 960,963 | 955,737 | 955,737 |
| Taxes Receivable | 39,187 | -- | 207,303 | 161,063 | 115,443 | 71,782 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -345,375 | -- | -855,457 | -1.5M | -1.1M | -699,207 |
| Cash Flow From Continuing Operating Activities | -345,375 | -- | -855,457 | -1.5M | -1.1M | -699,207 |
| Depreciation And Amortization | 10,468 | -- | 11,032 | 11,032 | 11,032 | 15,791 |
| Depreciation Amortization Depletion | 10,468 | -- | 11,032 | 11,032 | 11,032 | 15,791 |
| Stock Based Compensation | 889,166 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Working Capital | 109,012 | -- | -177,154 | -37,454 | -90,222 | -70,088 |
| Change In Receivables | 2,568 | -- | -43,482 | -44,727 | -26,258 | -5,819 |
| Change In Payables And Accrued Expense | 94,617 | -- | -133,942 | 27,713 | -69,479 | -82,947 |
| Other Non Cash Items | -- | -- | -- | -- | -- | 30,500 |
| Capital Expenditure | -92,364 | -12,175 | -7,270 | -- | -- | -- |
| Purchase Of PPE | -73,169 | -- | -- | -- | 0.00 | 0.00 |
| Net PPE Purchase And Sale | 4,331 | -- | -- | -- | 0.00 | -15,000 |
| Purchase Of Business | -- | -- | 0.00 | -- | -- | 0.00 |
| Sale Of Investment | 174,079 | -- | 20,185 | 68,780 | 0.00 | -- |
| Net Investment Purchase And Sale | 174,079 | -- | 20,185 | 68,780 | 0.00 | -- |
| Investing Cash Flow | 159,215 | -- | 12,915 | 63,554 | 0.00 | -15,000 |
| Cash Flow From Continuing Investing Activities | 159,215 | -- | 12,915 | 63,554 | 0.00 | -15,000 |
| Issuance Of Capital Stock | -- | -- | 220,000 | -- | -- | 0.00 |
| Net Common Stock Issuance | -- | -- | 220,000 | -- | -- | 0.00 |
| Financing Cash Flow | 907,500 | -- | 207,820 | 1.4M | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 907,500 | -- | 207,820 | 1.4M | 0.00 | 0.00 |
| Changes In Cash | 721,340 | -- | -634,722 | 33,813 | -1.1M | -714,207 |
| Beginning Cash Position | 1.1M | -- | 1.5M | 3.8M | 4.9M | 3.2M |
| End Cash Position | 1.8M | -- | 864,044 | 1.5M | 3.8M | 2.5M |
| Free Cash Flow | -437,739 | -124,014 | -862,727 | -1.5M | -1.1M | -- |
| Amortization Cash Flow | -- | -- | -- | 125.00 | 125.00 | 156.00 |
| Amortization Of Intangibles | -- | -- | -- | 125.00 | 125.00 | 156.00 |
| Asset Impairment Charge | -- | -- | -- | -- | -- | 82,500 |
| Capital Expenditure Reported | -19,195 | -12,175 | -7,270 | -5,226 | 0.00 | -- |
| Change In Prepaid Assets | 11,827 | -- | 270.00 | -20,440 | 5,515 | 18,678 |
| Common Stock Issuance | -- | -- | 220,000 | -- | -- | 0.00 |
| Depreciation | 10,468 | -- | 11,032 | 11,032 | 11,032 | 15,791 |
| Earnings Losses From Equity Investments | 43,976 | -- | -39,040 | 0.00 | 0.00 | 147,612 |
| Gain Loss On Investment Securities | 630,721 | -- | -7,885 | -- | -- | -- |
| Gain Loss On Sale Of PPE | -39,326 | -- | -- | -- | 0.00 | -9,590 |
| Net Business Purchase And Sale | -- | -- | 0.00 | -- | -- | 0.00 |
| Net Income From Continuing Operations | -1.3M | -- | -678,533 | -1.4M | -1.0M | -1.0M |
| Net Other Financing Charges | -- | -- | -12,180 | -- | -- | 0.00 |
| Operating Gains Losses | 635,371 | -- | -46,925 | -- | -- | 138,022 |
| Proceeds From Stock Option Exercised | 907,500 | -- | -- | -- | 0.00 | -- |
| Sale Of PPE | 77,500 | -- | -- | -- | 0.00 | -15,000 |
| Unrealized Gain Loss On Investment Securities | -716,913 | -- | 36,123 | -18,205 | 39,443 | 134,711 |